Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms

Completed · Phase 2 · Has a placebo group

Conditions studied: GERD, Acid Reflux Disease, Heartburn, Regurgitation

In brief

This research study is being done to gather information about how to do further clinical studies using AZD3355 as an add-on treatment to proton pump inhibitors (PPI).

Key facts

Study ID
NCT00703534
Run by
AstraZeneca
People needed
478
Starts
2008-05-01
Expected to finish
2009-01-01
Last updated by the study team
2011-06-20

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.